Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the T Cell Specific Surface Glycoprotein CD28 industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
TheraMAB LLC
R&D Systems
Atox Bio Ltd
Xencor
Five Prime Therapeutics Inc
Bristol-Myers Squibb Co
OSE Immunotherapeutics
Johnson & Johnson
Acro Bio Systems
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
FPT-155
FR-104
Lulizumab Pegol
Others
Application:
Plaque Psoriasis
Solid Tumor
Acute Renal Failure(ARF)
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 T Cell Specific Surface Glycoprotein CD28 Industry Overview
-
1.1.1 T Cell Specific Surface Glycoprotein CD28 Market Scope and Market Segments
-
1.1.2 T Cell Specific Surface Glycoprotein CD28 Industry Characteristics
-
1.1.3 Global and China T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China T Cell Specific Surface Glycoprotein CD28 Production Value and Growth Rate (2017-2028)
-
1.2 Global T Cell Specific Surface Glycoprotein CD28 Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 FPT-155
-
1.2.2 FR-104
-
1.2.3 Lulizumab Pegol
-
1.2.4 Others
-
1.3 Global T Cell Specific Surface Glycoprotein CD28 Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Plaque Psoriasis
-
1.3.2 Solid Tumor
-
1.3.3 Acute Renal Failure(ARF)
-
1.3.4 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America T Cell Specific Surface Glycoprotein CD28 Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe T Cell Specific Surface Glycoprotein CD28 Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC T Cell Specific Surface Glycoprotein CD28 Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global T Cell Specific Surface Glycoprotein CD28 Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China T Cell Specific Surface Glycoprotein CD28 Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China T Cell Specific Surface Glycoprotein CD28 Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global T Cell Specific Surface Glycoprotein CD28 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 T Cell Specific Surface Glycoprotein CD28 Industry Porter's Five Forces Model Analysis
-
2.2.3 T Cell Specific Surface Glycoprotein CD28 Industry PEST Analysis
-
2.3 T Cell Specific Surface Glycoprotein CD28 Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 T Cell Specific Surface Glycoprotein CD28 Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on T Cell Specific Surface Glycoprotein CD28 Industry
Chapter 3 Global and China T Cell Specific Surface Glycoprotein CD28 Market, by Manufacturer
-
3.1 Global and China T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China T Cell Specific Surface Glycoprotein CD28 Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China T Cell Specific Surface Glycoprotein CD28 Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China T Cell Specific Surface Glycoprotein CD28 Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China T Cell Specific Surface Glycoprotein CD28 Market Top 3 Players
Chapter 4 Global and China T Cell Specific Surface Glycoprotein CD28 Market, by Type (2017-2028)
-
4.1 T Cell Specific Surface Glycoprotein CD28 Market Trend, by Type
-
4.2 Global T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global T Cell Specific Surface Glycoprotein CD28 Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global T Cell Specific Surface Glycoprotein CD28 Price Trend, by Type (2017-2028)
-
4.3 China T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China T Cell Specific Surface Glycoprotein CD28 Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China T Cell Specific Surface Glycoprotein CD28 Price Trend, by Type (2017-2028)
Chapter 5 Global and China T Cell Specific Surface Glycoprotein CD28 Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global T Cell Specific Surface Glycoprotein CD28 Sales Value and Market Share, by Application (2017-2028)
-
5.3 China T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China T Cell Specific Surface Glycoprotein CD28 Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global T Cell Specific Surface Glycoprotein CD28 Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China T Cell Specific Surface Glycoprotein CD28 Production, Import, Consumption and Export (2017-2022)
-
6.2 North America T Cell Specific Surface Glycoprotein CD28 Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe T Cell Specific Surface Glycoprotein CD28 Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC T Cell Specific Surface Glycoprotein CD28 Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America T Cell Specific Surface Glycoprotein CD28 Market Analysis
-
7.1 North America T Cell Specific Surface Glycoprotein CD28 Market, by Type
-
7.2 North America T Cell Specific Surface Glycoprotein CD28 Market, by Application
-
7.3 North America T Cell Specific Surface Glycoprotein CD28 Market Analysis and Forecast, by Country
-
7.3.1 United States T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe T Cell Specific Surface Glycoprotein CD28 Market Analysis
-
8.1 Europe T Cell Specific Surface Glycoprotein CD28 Market, by Type
-
8.2 Europe T Cell Specific Surface Glycoprotein CD28 Market, by Application
-
8.3 Europe T Cell Specific Surface Glycoprotein CD28 Market Analysis and Forecast, by Country
-
8.3.1 Germany T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC T Cell Specific Surface Glycoprotein CD28 Market Analysis
-
9.1 APAC T Cell Specific Surface Glycoprotein CD28 Market, by Type
-
9.2 APAC T Cell Specific Surface Glycoprotein CD28 Market, by Application
-
9.3 APAC T Cell Specific Surface Glycoprotein CD28 Market Analysis and Forecast, by Country
-
9.3.1 China T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Analysis
-
10.1 Latin America, Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market, by Type
-
10.2 Latin America, Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market, by Application
-
10.3 Latin America, Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina T Cell Specific Surface Glycoprotein CD28 Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China T Cell Specific Surface Glycoprotein CD28 Company Profiles
-
11.1 TheraMAB LLC
-
11.1.1 TheraMAB LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product Profiles, Application and Specification
-
11.1.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 R&D Systems
-
11.2.1 R&D Systems Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 R&D Systems T Cell Specific Surface Glycoprotein CD28 Product Profiles, Application and Specification
-
11.2.3 R&D Systems T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Atox Bio Ltd
-
11.3.1 Atox Bio Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product Profiles, Application and Specification
-
11.3.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Xencor
-
11.4.1 Xencor Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Xencor T Cell Specific Surface Glycoprotein CD28 Product Profiles, Application and Specification
-
11.4.3 Xencor T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Five Prime Therapeutics Inc
-
11.5.1 Five Prime Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product Profiles, Application and Specification
-
11.5.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Bristol-Myers Squibb Co
-
11.6.1 Bristol-Myers Squibb Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product Profiles, Application and Specification
-
11.6.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 OSE Immunotherapeutics
-
11.7.1 OSE Immunotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 OSE Immunotherapeutics T Cell Specific Surface Glycoprotein CD28 Product Profiles, Application and Specification
-
11.7.3 OSE Immunotherapeutics T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Johnson & Johnson
-
11.8.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product Profiles, Application and Specification
-
11.8.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Acro Bio Systems
-
11.9.1 Acro Bio Systems Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Acro Bio Systems T Cell Specific Surface Glycoprotein CD28 Product Profiles, Application and Specification
-
11.9.3 Acro Bio Systems T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 T Cell Specific Surface Glycoprotein CD28 Industry Investment Prospect and Risk Assessment
-
12.1 T Cell Specific Surface Glycoprotein CD28 Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 T Cell Specific Surface Glycoprotein CD28 Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure China T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Production Value and Growth Rate (2017-2028)
-
Figure China T Cell Specific Surface Glycoprotein CD28 Production Value and Growth Rate (2017-2028)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Market Size and Growth Rate of FPT-155 (2017-2028)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Market Size and Growth Rate of FR-104 (2017-2028)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Market Size and Growth Rate of Lulizumab Pegol (2017-2028)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Market Size and Growth Rate of Others (2017-2028)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Market Size and Growth Rate of Plaque Psoriasis (2017-2028)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Market Size and Growth Rate of Solid Tumor (2017-2028)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Market Size and Growth Rate of Acute Renal Failure(ARF) (2017-2028)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Market Size and Growth Rate of Others (2017-2028)
-
Figure North America T Cell Specific Surface Glycoprotein CD28 Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe T Cell Specific Surface Glycoprotein CD28 Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC T Cell Specific Surface Glycoprotein CD28 Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China T Cell Specific Surface Glycoprotein CD28 Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China T Cell Specific Surface Glycoprotein CD28 Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China T Cell Specific Surface Glycoprotein CD28 Sales Value, by Manufacturer (2021&2022)
-
Table Global and China T Cell Specific Surface Glycoprotein CD28 Market Share, by Manufacturer (2021&2022)
-
Figure Global and China T Cell Specific Surface Glycoprotein CD28 Market Share, by Manufacturer in 2021
-
Figure Global and China T Cell Specific Surface Glycoprotein CD28 Market Share, by Manufacturer in 2022
-
Table Global T Cell Specific Surface Glycoprotein CD28 Sales Volume, by Type (2017-2028)
-
Table Global T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Type (2017-2028)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Type (2017-2028)
-
Table Global T Cell Specific Surface Glycoprotein CD28 Sales Value, by Type (2017-2028)
-
Table Global T Cell Specific Surface Glycoprotein CD28 Sales Value Share, by Type (2017-2028)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Price Trend, by Type (2017-2028)
-
Table China T Cell Specific Surface Glycoprotein CD28 Sales Volume, by Type (2017-2028)
-
Table China T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Type (2017-2028)
-
Figure China T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Type (2017-2028)
-
Table China T Cell Specific Surface Glycoprotein CD28 Sales Value, by Type (2017-2028)
-
Table China T Cell Specific Surface Glycoprotein CD28 Sales Value Share, by Type (2017-2028)
-
Figure China T Cell Specific Surface Glycoprotein CD28 Price Trend, by Type (2017-2028)
-
Table Global T Cell Specific Surface Glycoprotein CD28 Sales Volume, by Application (2017-2028)
-
Table Global T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Application (2017-2028)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Application (2017-2028)
-
Table Global T Cell Specific Surface Glycoprotein CD28 Sales Value, by Application (2017-2028)
-
Table Global T Cell Specific Surface Glycoprotein CD28 Sales Value Share, by Application (2017-2028)
-
Figure Global T Cell Specific Surface Glycoprotein CD28 Sales Value Share, by Application (2017-2028)
-
Table China T Cell Specific Surface Glycoprotein CD28 Sales Volume, by Application (2017-2028)
-
Table China T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Application (2017-2028)
-
Figure China T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Application (2017-2028)
-
Table China T Cell Specific Surface Glycoprotein CD28 Sales Value, by Application (2017-2028)
-
Table China T Cell Specific Surface Glycoprotein CD28 Sales Value Share, by Application (2017-2028)
-
Figure China T Cell Specific Surface Glycoprotein CD28 Sales Value Share, by Application (2017-2028)
-
Figure China T Cell Specific Surface Glycoprotein CD28 Production, Import, Consumption and Export (2017-2022)
-
Figure North America T Cell Specific Surface Glycoprotein CD28 Production, Import, Consumption and Export (2017-2022)
-
Figure Europe T Cell Specific Surface Glycoprotein CD28 Production, Import, Consumption and Export (2017-2022)
-
Figure APAC T Cell Specific Surface Glycoprotein CD28 Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Production, Import, Consumption and Export (2017-2022)
-
Table North America T Cell Specific Surface Glycoprotein CD28 Sales Volume, by Type (2017-2028)
-
Table North America T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Type (2017-2028)
-
Figure North America T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Type (2017-2028)
-
Table North America T Cell Specific Surface Glycoprotein CD28 Sales Volume, by Application (2017-2028)
-
Table North America T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Application (2017-2028)
-
Figure North America T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Application (2017-2028)
-
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure Canada T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Canada T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure Mexico T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Table Europe T Cell Specific Surface Glycoprotein CD28 Sales Volume, by Type (2017-2028)
-
Table Europe T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Type (2017-2028)
-
Figure Europe T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Type (2017-2028)
-
Table Europe T Cell Specific Surface Glycoprotein CD28 Sales Volume, by Application (2017-2028)
-
Table Europe T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Application (2017-2028)
-
Figure Europe T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Application (2017-2028)
-
Figure Germany T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Germany T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure UK T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure UK T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure France T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure France T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure Italy T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Italy T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure Spain T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Spain T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure Belgium T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure Poland T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Poland T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure Russia T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Russia T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure Turkey T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Table APAC T Cell Specific Surface Glycoprotein CD28 Sales Volume, by Type (2017-2028)
-
Table APAC T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Type (2017-2028)
-
Figure APAC T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Type (2017-2028)
-
Table APAC T Cell Specific Surface Glycoprotein CD28 Sales Volume, by Application (2017-2028)
-
Table APAC T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Application (2017-2028)
-
Figure APAC T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Application (2017-2028)
-
Figure China T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure China T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure Japan T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Japan T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure India T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure India T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure South Korea T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure Brazil T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure South Africa T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Figure Argentina T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina T Cell Specific Surface Glycoprotein CD28 Sales Value and Growth Rate (2017-2028)
-
Table TheraMAB LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table TheraMAB LLC Product Profiles, Application and Specification
-
Table TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table R&D Systems Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table R&D Systems Product Profiles, Application and Specification
-
Table R&D Systems T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Atox Bio Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Atox Bio Ltd Product Profiles, Application and Specification
-
Table Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Xencor Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Xencor Product Profiles, Application and Specification
-
Table Xencor T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Five Prime Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Five Prime Therapeutics Inc Product Profiles, Application and Specification
-
Table Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb Co Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table OSE Immunotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table OSE Immunotherapeutics Product Profiles, Application and Specification
-
Table OSE Immunotherapeutics T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Johnson & Johnson Product Profiles, Application and Specification
-
Table Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Acro Bio Systems Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Acro Bio Systems Product Profiles, Application and Specification
-
Table Acro Bio Systems T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
